Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2022		Oct. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss, including amounts attributable to noncontrolling interest	$ (138,575)		$ (110,796)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	88,926		17,242
Amortization of intangible assets	1,767		251
Depreciation expense	2,198		0
Amortization of deferred contract acquisition costs	32,693		23,555
Gain from deconsolidation of Meltano Inc.	(17,798)		0
Loss from equity method investment	2,247		0
Net amortization of premiums or discounts on short-term investments	(3,346)		0
Unrealized foreign exchange (gain) loss	(4,081)		19,752
Other non-cash (income) expense	439		(128)
Changes in assets and liabilities:
Accounts receivable	(22,163)		(17,350)
Prepaid expenses and other current assets	(5,320)		(3,373)
Deferred contract acquisition costs	(33,145)		(24,642)
Other long-term assets	2,050		(3,120)
Accounts payable	1,393		1,786
Accrued expenses and other current liabilities	3,249		1,019
Accrued compensation and benefits	(15,150)		3,812
Deferred revenue	40,200		41,469
Other long-term liabilities	(1,272)		1,803
Net cash used in operating activities	(65,688)		(48,720)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of short-term investments	(631,951)		(100,031)
Proceeds from maturities of short-term investments	122,701		0
Purchases of property and equipment	(5,018)		0
Deconsolidation of Meltano Inc.	(9,620)		0
Net cash used in investing activities	(523,888)		(100,031)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from initial public offering, net of underwriting discounts	0		654,552
Proceeds from the issuance of common stock upon exercise of stock options, including early exercises, net of repurchases	17,454		14,574
Issuance of common stock under employee stock purchase plan	9,554		0
Repurchase of common stock in a tender offer	0		(590)
Contributions received from noncontrolling interests, net of issuance costs	61,726		26,450
Partial settlement of acquisition related contingent cash consideration	(3,137)		0
Payments of deferred offering costs	0		(3,398)
Net cash provided by financing activities	85,597		691,588
Impact of foreign exchange on cash and cash equivalents	(8,524)		(973)
Net increase (decrease) in cash and cash equivalents	(512,503)		541,864
Cash, cash equivalents, and restricted cash at beginning of period	887,172		282,850
Cash, cash equivalents, and restricted cash at end of period	374,669		824,714
Supplemental disclosure of cash flow information:
Cash paid for income taxes	527		1,111
Cash donations	0		1,000
Vesting of early exercised stock options	4,106		5,425
Issuance of common stock upon conversion of preferred stock	0		424,904
Unpaid deferred offering costs	0		1,309
Reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets to the amounts shown in the consolidated statements of cash flows above:
Cash and cash equivalents	372,169	[1]	824,714
Restricted cash, current included in prepaid expenses and other current assets	2,500		0
Total cash, cash equivalents and restricted cash	$ 374,669		$ 824,714

[1] (1) As of October 31, 2022 and January 31, 2022, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $59.5 million and $17.7 million, respectively, and liabilities of $4.5 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.